Fidelity Asia Ventures

Fidelity Asia Ventures (FAV) is the Asian venture and growth capital arm of Fidelity International Ltd. (FIL), a part of the global Fidelity investment organization. The company has offices in Hong Kong, Beijing, Shanghai and Mumbai. Its investments and exits includeAlibaba Holdings, Pharmanex (Acquired by Nu Skin), Wuxi PharmaTech, Hurray!, Linktone, AsiaInfo, Dianji Technology, CDP, Datuu, XunleiXunlei, Isoftstone and Asia Renal Care (acquired by Bumrungrad International).

Fidelity Asia Ventures is a venture capital firm in Shanghai that prefers to invest in companies within the technology and healthcare sectors. Founded in One Corporate Avenue, Shanghai, China, it typically invests in early stage ventures. Its its US affiliate is Fidelity BiosciencesFidelity Biosciences.

Fidelity Asia Ventures (FAV) is the Asian venture and growth capital arm of Fidelity International Ltd. (FIL), a part of the global Fidelity investment organization. The company has offices in Hong Kong, Beijing, Shanghai and Mumbai. Its investments and exits includeAlibaba Holdings, Pharmanex (Acquired by Nu Skin), Wuxi PharmaTechWuxi PharmaTech, Hurray!, Linktone, AsiaInfo, Dianji Technology, CDP, Datuu, Xunlei, Isoftstone and Asia Renal Care (acquired by Bumrungrad International).

Fidelity Asia Ventures is a venture capital firm in Shanghai that prefers to invest in companies within the technology and healthcare sectors. Founded in One Corporate Avenue, Shanghai, ChinaChina, it typically invests in early stage ventures. Its its US affiliate is Fidelity Biosciences.

Fidelity Asia Ventures (FAV) is the Asian venture and growth capital arm of Fidelity International Ltd. (FIL), a part of the global Fidelity investment organization. The company has offices in Hong Kong, Beijing, Shanghai and MumbaiMumbai. Its investments and exits includeAlibaba Holdings, Pharmanex (Acquired by Nu Skin), Wuxi PharmaTech, Hurray!, Linktone, AsiaInfo, Dianji Technology, CDP, Datuu, Xunlei, Isoftstone and Asia Renal Care (acquired by Bumrungrad International).

Fidelity Asia Ventures (FAV) is the Asian venture and growth capital arm of Fidelity International Ltd. (FIL), a part of the global Fidelity investment organization. The company has offices in Hong KongHong Kong, Beijing, Shanghai and Mumbai. Its investments and exits includeAlibaba Holdings, Pharmanex (Acquired by Nu Skin), Wuxi PharmaTech, Hurray!, Linktone, AsiaInfo, Dianji Technology, CDP, Datuu, Xunlei, Isoftstone and Asia Renal Care (acquired by Bumrungrad International).

Fidelity Asia Ventures (FAV) is the Asian venture and growth capital arm of Fidelity International Ltd. (FIL), a part of the global Fidelity investment organization. The company has offices in Hong Kong, BeijingBeijing, Shanghai and Mumbai. Its investments and exits includeAlibaba Holdings, Pharmanex (Acquired by Nu Skin), Wuxi PharmaTech, Hurray!, Linktone, AsiaInfo, Dianji Technology, CDP, Datuu, Xunlei, Isoftstone and Asia Renal Care (acquired by Bumrungrad International).

Fidelity Asia Ventures is a venture capital firm in Shanghai that prefers to invest in companies within the technology and healthcare sectors. Founded in One Corporate Avenue, Shanghai, China, it typically invests in early stage ventures. Its its US affiliate is Fidelity Biosciences.

Fidelity Asia Ventures (FAV) is the Asian venture and growth capital arm of Fidelity International Ltd. (FIL), a part of the global Fidelity investment organization. The company has offices in Hong Kong, Beijing, Shanghai and Mumbai. Its investments and exits includeAlibaba Holdings, Pharmanex (Acquired by Nu Skin), Wuxi PharmaTech, Hurray!, Linktone, AsiaInfo, Dianji Technology, CDP, Datuu, Xunlei, Isoftstone and Asia Renal Care (acquired by Bumrungrad International).